A rationally designed macrocyclic cavitand that kills bacteria with high efficacy and good selectivity

Area of Science:

• Medicinal Chemistry
• Supramolecular Chemistry
• Antimicrobial Research

Background:

• The rise of antibiotic resistance necessitates the development of novel antibacterial agents.
• Macrocyclic compounds offer unique structural scaffolds for drug design.
• Cavitands, a class of macrocycles, have shown potential in various biological applications.

Purpose of the Study:

• To rationally design and synthesize a novel amphiphilic macrocyclic cavitand.
• To evaluate the antibacterial activity of the designed cavitand.
• To assess the selectivity of the cavitand towards bacterial cells over mammalian cells.

Main Methods:

• Rational design and synthesis of an amphiphilic macrocyclic cavitand.
• In vitro antibacterial assays against a panel of bacterial strains.
• Cytotoxicity assays using mammalian cell lines.

Main Results:

• The synthesized amphiphilic macrocyclic cavitand exhibited significant antibacterial activity.
• The compound's efficacy was comparable to established peptide-based antibiotics.
• Selective toxicity was observed, with minimal impact on mammalian cells.

Conclusions:

• Amphiphilic macrocyclic cavitands represent a promising class of novel antibacterial agents.
• Rational design can yield compounds with potent and selective antimicrobial properties.
• Further investigation into cavitand-based antibiotics is warranted.